China to make cheaper version of GSK’s flu drug

by Gayatri on  September 29, 2006 at 4:51 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

China to make cheaper version of GSK’s flu drug
GlaxoSmithKline signed an agreement with Simcere Pharmaceutical Group of Nanjing, China for it to manufacture and sell a cheaper version of its flu drug Relenza in poor countries.

The Chinese company can manufacture and sell zanamivir in China, Indonesia, Thailand, Vietnam and all least-developed countries, under the terms of licensing agreement.

"GSK is doing everything we can to prepare for a global influenza pandemic, including expanding production of Relenza and developing a pandemic vaccine," said David Stout, GSK's president of pharmaceutical operations. "This agreement with Simcere is intended to expand available supplies of zanamivir in areas of the world that may be on the front line of a possible influenza pandemic," Stout added.

Relenza is an inhaled drug and is meant to be a first-line defense in the event of an influenza pandemic set off by bird flu. It is approved in many countries around the world.

Source: Medindia
GYT

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Flu Swine Flu 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive